Publications

Exploring the evidence base for national and regional policy interventions to combat resistance.

DAR, OA; Hasan, R; Schlundt, J; Harbarth, S; CALEO, G; Dar, FK; Littmann, J; Rweyemamu, M; Buckley, EJ; Shahid, M; Kock, R; Li, HL; Giha, H; KHAN, M; So, AD; Bindayna, KM; KESSEL, A; Pedersen, HB; Permanand, G; Zumla, A; Røttingen, J-A; HEYMANN, DL;

2015

Lancet, (2015).387 10015 10.1016/S0140-6736(15)00520-6.

Good quality locally procured drugs can be as effective as internationally quality assured drugs in treating multi-drug resistant tuberculosis.

Qadeer, E; Fatima, R; FIELDING, K; Qazi, F; MOORE, D; KHAN, MS;

2015

PloS one, (2015).10 4 10.1371/journal.pone.0126099.

Reply to "Drug Susceptibility of Genetically Engineered Trypanosoma cruzi Strains and Sterile Cure in Animal Models as a Criterion for Potential Clinical Efficacy of Anti-T. cruzi Drugs".

FRANCISCO, AF; LEWIS, MD; JAYAWARDHANA, S; TAYLOR, MC; Chatelain, E; KELLY, JM;

2015

Antimicrobial agents and chemotherapy, (2015).59 12 10.1128/AAC.02022-15.

Persistence of chloroquine-resistant haplotypes of Plasmodium falciparum in children with uncomplicated Malaria in Lagos, Nigeria, four years after change of chloroquine as first-line antimalarial medicine.

Oladipo, OO; Wellington, OA; SUTHERLAND, CJ;

2015

Diagnostic pathology, (2015).10 1 10.1186/s13000-015-0276-2.

Introducing rapid diagnostic tests for malaria into registered drug shops in Uganda: lessons learned and policy implications.

Mbonye, AK; CLARKE, SE; LAL, S; CHANDLER, CI; HUTCHINSON, E; HANSEN, KS; Magnussen, P;

2015

Malaria journal, (2015).14 1 10.1186/s12936-015-0979-6.

Economic evaluation of an alternative drug to sulfadoxine-pyrimethamine as intermittent preventive treatment of malaria in pregnancy.

Sicuri, E; FERNANDES, S; Macete, E; González, R; Mombo-Ngoma, G; Massougbodgi, A; Abdulla, S; Kuwawenaruwa, A; Katana, A; Desai, M; Cot, M; Ramharter, M; Kremsner, P; Slustker, L; Aponte, J; HANSON, K; Menéndez, C;

2015

PloS one, (2015).10 4 10.1371/journal.pone.0125072.

Multiple Origins of Mutations in the mdr1 Gene--A Putative Marker of Chloroquine Resistance in P. vivax.

Schousboe, ML; Ranjitkar, S; Rajakaruna, RS; Amerasinghe, PH; Morales, F; Pearce, R; Ord, R; LESLIE, T; ROWLAND, M; Gadalla, NB; Konradsen, F; Bygbjerg, IC; ROPER, C; Alifrangis, M;

2015

PLoS neglected tropical diseases, (2015).9 11 10.1371/journal.pntd.0004196.

Intercontinental dissemination of azithromycin-resistant shigellosis through sexual transmission: a cross-sectional study.

Baker, KS; Dallman, TJ; Ashton, PM; Day, M; HUGHES, G; Crook, PD; Gilbart, VL; Zittermann, S; Allen, VG; Howden, BP; Tomita, T; Valcanis, M; Harris, SR; Connor, TR; Sintchenko, V; Howard, P; Brown, JD; Petty, NK; Gouali, M; Thanh, DP; Keddy, KH; Smith, AM; Talukder, KA; Faruque, SM; Parkhill, J; ... THOMSON, NR.

2015

The Lancet infectious diseases, (2015).15 8 10.1016/S1473-3099(15)00002-X.

Microscopic Observation Drug Susceptibility Assay for Rapid Diagnosis of Lymph Node Tuberculosis and Detection of Drug Resistance.

Kirwan, DE; Ugarte-Gil, C; Gilman, RH; Caviedes, L; Rizvi, H; Ticona, E; Chavez, G; Cabrera, JL; Matos, ED; Evans, CA; MOORE, DA J; Friedland, JS; Lymph Node TB Working Group, Peru,;

2015

Journal of clinical microbiology, (2015).54 1 10.1128/JCM.02227-15.

Antimicrobial resistance and management of invasive Salmonella disease.

Kariuki, S; Gordon, MA; Feasey, N; PARRY, CM;

2015

Vaccine, (2015).33 Sup 0 3 10.1016/j.vaccine.2015.03.102.